SEP11_HUMAN - dbPTM
SEP11_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SEP11_HUMAN
UniProt AC Q9NVA2
Protein Name Septin-11
Gene Name 11-Sep
Organism Homo sapiens (Human).
Sequence Length 429
Subcellular Localization Cytoplasm, cytoskeleton. Cell junction, synapse. Cell projection, dendritic spine. Cell projection, axon. Partly colocalizes with stress fibers and microtubules. During bacterial infection, displays a collar shape structure next to actin at the pole
Protein Description Filament-forming cytoskeletal GTPase. May play a role in cytokinesis (Potential). May play a role in the cytoarchitecture of neurons, including dendritic arborization and dendritic spines, and in GABAergic synaptic connectivity (By similarity). During Listeria monocytogenes infection, not required for the bacterial entry process, but restricts its efficacy..
Protein Sequence MAVAVGRPSNEELRNLSLSGHVGFDSLPDQLVNKSTSQGFCFNILCVGETGIGKSTLMDTLFNTKFESDPATHNEPGVRLKARSYELQESNVRLKLTIVDTVGFGDQINKDDSYKPIVEYIDAQFEAYLQEELKIKRSLFNYHDTRIHACLYFIAPTGHSLKSLDLVTMKKLDSKVNIIPIIAKADTIAKNELHKFKSKIMSELVSNGVQIYQFPTDEETVAEINATMSVHLPFAVVGSTEEVKIGNKMAKARQYPWGVVQVENENHCDFVKLREMLIRVNMEDLREQTHTRHYELYRRCKLEEMGFKDTDPDSKPFSLQETYEAKRNEFLGELQKKEEEMRQMFVMRVKEKEAELKEAEKELHEKFDLLKRTHQEEKKKVEDKKKELEEEVNNFQKKKAAAQLLQSQAQQSGAQQTKKDKDKKNASFT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAVAVGRPS
------CCEECCCCC
9.6612665801
9PhosphorylationAVAVGRPSNEELRNL
CEECCCCCHHHHHCC
56.3529255136
9O-linked_GlycosylationAVAVGRPSNEELRNL
CEECCCCCHHHHHCC
56.3523301498
17PhosphorylationNEELRNLSLSGHVGF
HHHHHCCCCCCCCCC
24.8428450419
19PhosphorylationELRNLSLSGHVGFDS
HHHCCCCCCCCCCCC
24.3928450419
26PhosphorylationSGHVGFDSLPDQLVN
CCCCCCCCCCHHHCC
39.2726699800
46GlutathionylationGFCFNILCVGETGIG
CCCEEEEEECCCCCC
3.0622555962
50PhosphorylationNILCVGETGIGKSTL
EEEEECCCCCCHHHH
28.33-
55PhosphorylationGETGIGKSTLMDTLF
CCCCCCHHHHHHHHH
22.8921712546
56PhosphorylationETGIGKSTLMDTLFN
CCCCCHHHHHHHHHC
29.5921712546
64PhosphorylationLMDTLFNTKFESDPA
HHHHHHCCCCCCCCC
29.7621712546
65UbiquitinationMDTLFNTKFESDPAT
HHHHHCCCCCCCCCC
48.52-
65AcetylationMDTLFNTKFESDPAT
HHHHHCCCCCCCCCC
48.5226051181
75 (in isoform 2)Ubiquitination-35.51-
84PhosphorylationGVRLKARSYELQESN
CCEEEEEEEECHHCC
28.0228152594
85PhosphorylationVRLKARSYELQESNV
CEEEEEEEECHHCCC
18.3328152594
90PhosphorylationRSYELQESNVRLKLT
EEEECHHCCCEEEEE
27.8824076635
145PhosphorylationSLFNYHDTRIHACLY
HHHCCHHHHHEEEEE
20.43-
163PhosphorylationPTGHSLKSLDLVTMK
CCCCCCCCCCEEEHH
32.2020068231
168PhosphorylationLKSLDLVTMKKLDSK
CCCCCEEEHHHCCCC
30.4820068231
170UbiquitinationSLDLVTMKKLDSKVN
CCCEEEHHHCCCCCC
40.60-
175UbiquitinationTMKKLDSKVNIIPII
EHHHCCCCCCEEEEE
38.68-
184UbiquitinationNIIPIIAKADTIAKN
CEEEEEECCCHHHHH
36.06-
190AcetylationAKADTIAKNELHKFK
ECCCHHHHHHHHHHH
47.2925953088
190MalonylationAKADTIAKNELHKFK
ECCCHHHHHHHHHHH
47.2926320211
194 (in isoform 2)Ubiquitination-27.59-
294PhosphorylationEQTHTRHYELYRRCK
HHHHHHHHHHHHHHC
12.35-
297PhosphorylationHTRHYELYRRCKLEE
HHHHHHHHHHHCHHH
5.53-
301UbiquitinationYELYRRCKLEEMGFK
HHHHHHHCHHHCCCC
58.06-
308UbiquitinationKLEEMGFKDTDPDSK
CHHHCCCCCCCCCCC
54.73-
310PhosphorylationEEMGFKDTDPDSKPF
HHCCCCCCCCCCCCC
50.45-
311 (in isoform 2)Ubiquitination-55.96-
314PhosphorylationFKDTDPDSKPFSLQE
CCCCCCCCCCCCHHH
47.84-
315UbiquitinationKDTDPDSKPFSLQET
CCCCCCCCCCCHHHH
58.42-
318 (in isoform 2)Ubiquitination-37.36-
318PhosphorylationDPDSKPFSLQETYEA
CCCCCCCCHHHHHHH
37.3626657352
322PhosphorylationKPFSLQETYEAKRNE
CCCCHHHHHHHHHHH
17.4425627689
323PhosphorylationPFSLQETYEAKRNEF
CCCHHHHHHHHHHHH
17.0925159151
325 (in isoform 2)Ubiquitination-12.99-
325UbiquitinationSLQETYEAKRNEFLG
CHHHHHHHHHHHHHH
12.9921906983
326 (in isoform 1)Ubiquitination-43.7621890473
326UbiquitinationLQETYEAKRNEFLGE
HHHHHHHHHHHHHHH
43.76-
336UbiquitinationEFLGELQKKEEEMRQ
HHHHHHHHHHHHHHH
74.83-
336 (in isoform 2)Ubiquitination-74.8321890473
337UbiquitinationFLGELQKKEEEMRQM
HHHHHHHHHHHHHHH
58.35-
346 (in isoform 2)Ubiquitination-1.69-
347 (in isoform 2)Ubiquitination-2.52-
357UbiquitinationKEKEAELKEAEKELH
HHHHHHHHHHHHHHH
46.51-
361AcetylationAELKEAEKELHEKFD
HHHHHHHHHHHHHHH
73.0428735889
366UbiquitinationAEKELHEKFDLLKRT
HHHHHHHHHHHHHHH
33.17-
367 (in isoform 2)Ubiquitination-7.93-
378AcetylationKRTHQEEKKKVEDKK
HHHHHHHHHHHHHHH
58.0830592309
381 (in isoform 2)Ubiquitination-18.47-
388 (in isoform 2)Ubiquitination-16.05-
397AcetylationEEVNNFQKKKAAAQL
HHHHHHHHHHHHHHH
52.7026051181
397SuccinylationEEVNNFQKKKAAAQL
HHHHHHHHHHHHHHH
52.7023954790
399UbiquitinationVNNFQKKKAAAQLLQ
HHHHHHHHHHHHHHH
50.74-
399MalonylationVNNFQKKKAAAQLLQ
HHHHHHHHHHHHHHH
50.7426320211
407PhosphorylationAAAQLLQSQAQQSGA
HHHHHHHHHHHHHCC
27.7025850435
412PhosphorylationLQSQAQQSGAQQTKK
HHHHHHHHCCHHCHH
24.8225850435
417PhosphorylationQQSGAQQTKKDKDKK
HHHCCHHCHHHHCCC
28.1630242111
418UbiquitinationQSGAQQTKKDKDKKN
HHCCHHCHHHHCCCC
55.42-
418AcetylationQSGAQQTKKDKDKKN
HHCCHHCHHHHCCCC
55.4226051181
418MalonylationQSGAQQTKKDKDKKN
HHCCHHCHHHHCCCC
55.4226320211
427PhosphorylationDKDKKNASFT-----
HHCCCCCCCC-----
38.5226853621
428UbiquitinationKDKKNASFT------
HCCCCCCCC------
9.7421906983

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SEP11_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SEP11_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SEP11_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SEPT9_HUMANSEPT9physical
22939629
SEPT7_HUMANSEPT7physical
22939629
SEPT5_HUMANSEPT5physical
22939629
TM189_HUMANTMEM189physical
22939629
STIM1_HUMANSTIM1physical
22939629
SUCA_HUMANSUCLG1physical
22939629
XRCC1_HUMANXRCC1physical
22939629
SIN3A_HUMANSIN3Aphysical
22939629
THTR_HUMANTSTphysical
22939629
TCOF_HUMANTCOF1physical
22939629
TOM40_HUMANTOMM40physical
22939629
SOSB1_HUMANNABP2physical
22939629
TM177_HUMANTMEM177physical
22939629
TMEM9_HUMANTMEM9physical
22939629
VDAC2_HUMANVDAC2physical
22939629
SMCA2_HUMANSMARCA2physical
22939629
THTM_HUMANMPSTphysical
22939629
SF01_HUMANSF1physical
22939629
SEPT5_HUMANSEPT5physical
26344197
SEPT9_HUMANSEPT9physical
26344197
PRCC_HUMANPRCCphysical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SEP11_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides.";
Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.;
Nat. Biotechnol. 21:566-569(2003).
Cited for: PROTEIN SEQUENCE OF 2-14 (ISOFORM 1), AND ACETYLATION AT ALA-2.

TOP